
  <style>
  .gh-table table { 
    border-collapse: collapse; 
    width: 100%;
    border: 1px solid #444;
    font-size: 12px;
  }
  .gh-table th, .gh-table td { 
    border: 1px solid #444; 
    padding: 4px 6px; 
    vertical-align: top;
    font-weight: 400 !important;   /* regular font */
  }
  .gh-table th { 
    .gh-table th { background: #f5f5f5; text-align: left; }
  }
  .gh-table th { font-weight: 700 !important; }
    @media print {
      .gh-table { font-size: 10px; }
    }
  </style>
  <div class='gh-table'><table><thead><tr><th>Molecola (1)</th><th>Molecola (2)</th><th>description</th></tr></thead><tbody><tr><td>Acetylsalicylic acid</td><td>Bisoprolol</td><td>Acetylsalicylic acid may decrease the antihypertensive activities of Bisoprolol.</td></tr><tr><td>Budesonide</td><td>Acetylsalicylic acid</td><td>The risk or severity of gastrointestinal irritation can be increased when
Budesonide is combined with Acetylsalicylic acid.</td></tr><tr><td>Budesonide</td><td>Bisoprolol</td><td>Bisoprolol may decrease the excretion rate of Budesonide which could result in a
higher serum level.</td></tr><tr><td>Budesonide</td><td>Cholecalciferol</td><td>The therapeutic efficacy of Cholecalciferol can be decreased when used in
combination with Budesonide.</td></tr><tr><td>Formoterol</td><td>Acetylsalicylic acid</td><td>The risk or severity of hypertension can be increased when Acetylsalicylic acid
is combined with Formoterol.</td></tr><tr><td>Formoterol</td><td>Bisoprolol</td><td>The therapeutic efficacy of Formoterol can be decreased when used in combination
with Bisoprolol.</td></tr><tr><td>Formoterol</td><td>Cholecalciferol</td><td>The metabolism of Formoterol can be decreased when combined with
Cholecalciferol.</td></tr><tr><td>Formoterol</td><td>Furosemide</td><td>The risk or severity of hypokalemia can be increased when Formoterol is combined
with Furosemide.</td></tr><tr><td>Formoterol</td><td>Pantoprazole</td><td>The metabolism of Formoterol can be decreased when combined with Pantoprazole.</td></tr><tr><td>Formoterol</td><td>Umeclidinium</td><td>The metabolism of Umeclidinium can be decreased when combined with Formoterol.</td></tr><tr><td>Furosemide</td><td>Acetylsalicylic acid</td><td>The risk or severity of increased serum creatinine can be increased when
Acetylsalicylic acid is combined with Furosemide.</td></tr><tr><td>Furosemide</td><td>Bisoprolol</td><td>Bisoprolol may increase the hypotensive activities of Furosemide.</td></tr><tr><td>Furosemide</td><td>Budesonide</td><td>The risk or severity of hypokalemia can be increased when Budesonide is combined
with Furosemide.</td></tr><tr><td>Pantoprazole</td><td>Acetylsalicylic acid</td><td>Acetylsalicylic acid may decrease the excretion rate of Pantoprazole which could
result in a higher serum level.</td></tr><tr><td>Pantoprazole</td><td>Bisoprolol</td><td>Pantoprazole may decrease the excretion rate of Bisoprolol which could result in
a higher serum level.</td></tr><tr><td>Pantoprazole</td><td>Budesonide</td><td>Pantoprazole can cause a decrease in the absorption of Budesonide resulting in a
reduced serum concentration and potentially a decrease in efficacy.</td></tr><tr><td>Pantoprazole</td><td>Furosemide</td><td>Furosemide may decrease the excretion rate of Pantoprazole which could result in
a higher serum level.</td></tr><tr><td>Tenofovir alafenamide</td><td>Acetylsalicylic acid</td><td>The serum concentration of Tenofovir alafenamide can be increased when it is
combined with Acetylsalicylic acid.</td></tr><tr><td>Tenofovir alafenamide</td><td>Bisoprolol</td><td>The serum concentration of Tenofovir alafenamide can be increased when it is
combined with Bisoprolol.</td></tr><tr><td>Tenofovir alafenamide</td><td>Budesonide</td><td>The serum concentration of Tenofovir alafenamide can be increased when it is
combined with Budesonide.</td></tr><tr><td>Tenofovir alafenamide</td><td>Furosemide</td><td>The serum concentration of Tenofovir alafenamide can be increased when it is
combined with Furosemide.</td></tr><tr><td>Tenofovir alafenamide</td><td>Pantoprazole</td><td>The serum concentration of Tenofovir alafenamide can be increased when it is
combined with Pantoprazole.</td></tr><tr><td>Umeclidinium</td><td>Bisoprolol</td><td>The serum concentration of Umeclidinium can be increased when it is combined
with Bisoprolol.</td></tr><tr><td>Umeclidinium</td><td>Cholecalciferol</td><td>The metabolism of Umeclidinium can be decreased when combined with
Cholecalciferol.</td></tr></tbody></table></div>
